Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | GENB Generate Biomedicines, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $17.14 +0.1% | $15.06 -2.0% |
| StockIQ Score | 75B+ Strong Risk: High | 36F Weak Risk: Medium |
| Technical | 72B | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 100A+ | 50C- |
| Quality | — | 50C- |
| Risk | 42D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Generate Biomedicines (GENB) outperforms Ascentage Pharma (AAPG) in investor and technical strength, scoring 61 and 55 respectively, compared to AAPG’s 37 and 18. GENB also carries a "MODERATE" rating, while AAPG is rated "WEAK." AAPG’s growth score of 50 is the only higher metric between the two.